TRAF7 mutations were shown to be involved in genesis of human cancer, especially in about 25% of meningiomas (Zotti et al., 2017), and de novo missense variants were also identified in ASD probands (Neale et al., 2012; Krumm et al., 2015; Tokita et al., 2018). Here, TRAF7 is linked to cancer.